Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times?

about

Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology.Mechanisms of termination and prevention of atrial fibrillation by drug therapy.

P2860

Q28066307-A9D53F96-ACDC-4DA0-A8B9-7F679122C01C Q35037364-642F7140-6238-4446-B134-9D52E4460089 Q37844891-44AFE38E-763B-4DBE-B658-CBEEA3A917F5

P2860

Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times?

Item

http://www.wikidata.org/entity/Q42584500

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Duration of heart failure and ...... mechanisms at different times?

@en

Duration of heart failure and ...... mechanisms at different times?

@nl

type

Item

label

Duration of heart failure and ...... mechanisms at different times?

@en

Duration of heart failure and ...... mechanisms at different times?

@nl

prefLabel

Duration of heart failure and ...... mechanisms at different times?

@en

Duration of heart failure and ...... mechanisms at different times?

@nl

P1476

Duration of heart failure and ...... mechanisms at different times?

@en

P2093

Andrew C Rankin

http://www.w3.org/2001/XMLSchema#string

Antony J Workman

http://www.w3.org/2001/XMLSchema#string

P2860

Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence.

Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF

Deleting the accessory subunit KChIP2 results in loss of I(to,f) and increased I(K,slow) that maintains normal action potential configuration.

Chronic heart failure and the substrate for atrial fibrillation.

Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.

Cellular bases for human atrial fibrillation.

Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure.

The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation.

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.

Characterization of sustained atrial tachycardia in dogs with rapid ventricular pacing-induced heart failure.

P304

180-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1093/CVR/CVP299

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26773187

http://www.w3.org/2001/XMLSchema#string

P698

19713283

http://www.w3.org/2001/XMLSchema#string

P932

2762576

http://www.w3.org/2001/XMLSchema#string

Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times?

about

P2860

P2860

Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932